Recent Activity

Loading...

ZURA

Zura Bio Limited Class A · NASDAQ

Performance

+31.52%

1W

+99.01%

1M

+55.13%

3M

+42.02%

6M

+29.55%

YTD

+13.94%

1Y

Profile

Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Technical Analysis of ZURA 2024-05-10

Overview:

In analyzing the technical indicators for ZURA stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming tradin...

See more ...

Recent News & Updates